More than 5 million people are now on ART in resource-limited countries, and the challenges of managing care at that volume are becoming apparent.
In a relatively short time, the number of people receiving antiretroviral therapy (ART) in resource-limited countries has risen dramatically — to more than 5 million. This remarkable scale-up of treatment has obviously been a challenge, and now the reality of widespread ART management is setting in.
One major problem that has come to light is that there are simply not enough physicians, let alone experienced ones, to take care of all the patients now on ART. “Task-shifting” has been proposed as a reasonable solution, but the evidence to support it has been limited. This year, a randomized trial in South Africa demonstrated that nurse-led monitoring of ART can be just as effective as physician-led monitoring. However, the outcomes in both gro…
Author
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)